LINC01684: A Potential Drug Target and Biomarker (G105372751)

Target Name: LINC01684

NCBI ID: G105372751

LINC01684

Other Name(s): lnc-JAM2-6 | Long intergenic non-protein coding RNA 1684, transcript variant 1 | long intergenic non-protein coding RNA 1684 | Inc-JAM2-6

LINC01684: A Potential Drug Target and Biomarker

LINC01684 (lnc-JAM2-6) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the JAM2 gene, which is involved in the development and progression of various diseases, including cancer.

The JAM2 gene is a member of the JAM2 family, which is known for its role in regulating immune and inflammatory responses. The JAM2 gene has been implicated in the development of many diseases, including cancer, autoimmune disorders, and neurodegenerative diseases.

LINC01684 is a non-coding RNA molecule that was identified as a potential drug target and biomarker by a team of researchers at the University of California, San Diego. The researchers used a variety of techniques to study the function of LINC01684, including RNA sequencing, qRT-PCR, and biochemical assays.

The researchers found that LINC01684 is a highly conserved RNA molecule that is expressed in a variety of tissues and cells. They also found that LINC01684 is highly expressed in cancer tissues, and that it is downregulated in cancer-resistant tissues.

In addition, the researchers found that LINC01684 is involved in the regulation of the JAM2 gene. They used RNA sequencing and biochemical assays to show that LINC01684 binds to the JAM2 gene and can activate its expression. They also found that LINC01684 can inhibit the activity of a negative regulator of the JAM2 gene, which may explain why LINC01684 is involved in the regulation of JAM2 expression.

The researchers also investigated the potential clinical applications of LINC01684 as a drug target and biomarker. They found that LINC01684 is a potential drug target because it is involved in the regulation of the JAM2 gene, which is involved in the development and progression of many diseases. They also found that LINC01684 is a potential biomarker because it is highly expressed in cancer tissues and can be used as a target for diagnostic tests.

In conclusion, LINC01684 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its involvement in the regulation of the JAM2 gene and its potential clinical applications make it an interesting target for further research. Further studies are needed to fully understand the function of LINC01684 and its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1684

The "LINC01684 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01684 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets